Searched for
PRICING FRAMEWORK DRUGS
Centre set to tighten oversight of pharma packaging materialsIndia is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...- India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...
- Drugmakers yet to see gains from government's minimum import price policyGovernment's Minimum Import Price (MIP) initiative to boost domestic drug makers faces a slow start. Despite setting price thresholds for k...
- Plan in the works to let hospitals import med equipment directlyIndia's drug regulator is proposing to allow hospitals to directly import advanced medical equipment like MRI and CT scanners, bypassing cu...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equities extended gains for a third straight session, with Sensex and Nifty rising on optimism over the Iran-US peace framework and ...
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
- Falling crude, stronger rupee could boost earnings outlook for India: Deepak ShenoyIndian stocks are poised for a favorable period. Falling crude oil prices and a strengthening rupee offer support. Macroeconomic conditions...
- How a pressure cooker's smell exposed a ganja dealer during Kerala Police raid, watch the viral videoPolice in Thrissur, Kerala, arrested a man after a drug raid. He attempted to hide ganja inside a pressure cooker filled with rice. The unu...
- Uzbekistan can provide more incentives to Indian pharma firms, aims to become regional hub for supplyUzbekistan is inviting Indian drug companies to invest more. They are offering better subsidies and technology help. This aims to make Uzbe...
- Coal minister flags unregulated expansion of online pharmaciesUnion minister G Kishan Reddy has written to the health minister about concerns over online pharmacies. These platforms are accused of deep...
- PSU closure: Govt sets in motion new move after years wasted in stop-start processThe Centre is pushing ministries to accelerate the closure of unprofitable state-owned companies. Progress has been slow despite a policy a...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- India losing investor attention to Asia’s AI-electronics surge, says DBS economistGlobal capital is shifting towards electronics and AI in Asia. India's foreign direct investment slowdown is not a major concern. Asia's ex...
- Donald Trump's drugmaker deals may save economy $529 billion over 10 years: White HousePresident Trump's administration projects significant savings from deals with drug companies. These agreements aim to lower US prescription...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- ET Most Innovative AI Product Awards 2026: Honouring the innovations powering India's next economyThe ET Most Innovative AI Product Awards 2026 brings together 11 distinct categories that reflect where artificial intelligence is deliveri...
- Drug regulator oversight sought for nutraceuticals; NGO flags quality, pricing concernsA Gujarat NGO is pushing the government to regulate nutraceuticals like medicines. They cite concerns about product quality and unregulated...
- Drug MNCs for keeping patient aid plan out of trade margin formulaThe Organisation of Pharmaceutical Producers of India (OPPI) recommended excluding Patient Assistance Programmes (PAPs) from Trade Margin R...
- Govt widens composition of drug, medical devices pricing reforms panelThe government has expanded a committee to look into pricing reforms for drugs and medical devices, including civil rights activists like A...
- Medical devices companies to soon have 'unique' pricing modelAt present there is no separate pricing framework followed for medical devices. The government has been using the same framework which was ...
Load More
